Analyses show that colibactin-related mutations are 3.3 times more common in young patients than in those diagnosed after the age of 70. This is striking evidence of the impact of this toxin on young organisms.

Analyses show that colibactin-related mutations are 3.3 times more common in young patients than in those diagnosed after the age of 70. This is striking evidence of the impact of this toxin on young organisms.